跳至主要内容
临床试验/NL-OMON46762
NL-OMON46762撤回不适用

Clinical pilot study to determine the feasibility of detecting pancreatic beta cells using Exendin-4-800CW targeting the glucagon-like peptide 1 receptor for future application of molecular fluorescence guided surgery in insulinoma patients (BETA-light) - Detecting beta cells with a fluorescent tracer (BETA-light)

niversitair Medisch Centrum Groningen0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age equal to or older than 18 years;- Patients who are scheduled to undergo a pancreatectomy due to an insulinoma, another type of neuro-endocrine tumour or because of a suspected carcinoma.;- WHO performance score 0-2;- Signed informed consent

排除标准

  • - Breast feeding;- Pregnancy or the wish to become pregnant within 6 months;- Calculated creatinine clearance below 40ml/min;- Evidence of other malignancy in conventional imaging (suspicious liver, bone and lung lesions);- No informed consent

研究者

相似试验

Clinical pilot study to determine the feasibility of... | 临床试验